Heart Test Laboratories I...
(HSCSW)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 |
| Net Income | -6.61M | -6.35M | -4.83M | -2.45M | -3.81M |
| Depreciation & Amortization | 95.13K | 26.91K | 26.57K | 33.61K | 63.83K |
| Stock-Based Compensation | 405.02K | 248.31K | 68.40K | 24.68K | 135.07K |
| Other Working Capital | -368.36K | 136.06K | 691.47K | 104.54K | -30.34K |
| Other Non-Cash Items | 539.23K | -100.97M | -35.59K | -248.54K | -21.79K |
| Deferred Income Tax | - | 101.10M | - | - | -10.02K |
| Change in Working Capital | -504.36K | 173.98K | 1.12M | 190.13K | -195.97K |
| Operating Cash Flow | -6.07M | -5.77M | -3.64M | -2.45M | -3.84M |
| Capital Expenditures | -125.27K | -18.31K | -1.93K | -712 | -11.42K |
| Acquisitions | - | - | - | - | 19.59K |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | -60.82K | - | - | - | 19.59K |
| Investing Cash Flow | -125.27K | -18.31K | -1.93K | -712 | 8.17K |
| Debt Repayment | 42.62K | -398.26K | 4.23M | 2.48M | 633.79K |
| Common Stock Repurchased | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | - | 1.31M | -385.14K | 200.00K | 1.18M |
| Financial Cash Flow | 10.34M | 6.53M | 3.84M | 2.68M | 1.81M |
| Net Cash Flow | 4.15M | 742.21K | 194.78K | 226.63K | -2.02M |
| Free Cash Flow | -6.20M | -5.79M | -3.65M | -2.45M | -3.85M |